What Are Product and Process-Related Impurities? (Definitions, Examples, and How to Interpret Them)

What You Need to Know

  • Product-related impurities are variants or degradation products derived from the drug substance (e.g. aggregates, fragments, modified forms).
  • Process-related impurities are contaminants introduced during the manufacturing process (e.g. host cell proteins, host cell DNA, reagents).
  • In biologics, impurities can be difficult to analyse due to co-elution, interactions and overlapping signals.
  • Reliable identification often requires orthogonal analytical techniques and expert interpretation.

What Are Product and Process-Related Impurities?

Product-related impurities are molecular variants that originate from the therapeutic protein itself due to degradation, modification or structural heterogeneity.

Process-related impurities are residual substances introduced during manufacturing, typically from the expression system, raw materials, or purification process.

While these definitions are clear, real-world impurity identification in biologics is often more complex. For example, in some analytical methods you may encounter peaks that could represent multiple species. With this in mind, the key challenge is not just identifying signals, but correctly interpreting what they represent.

What Are Product-Related Impurities? (Definition + Examples)

Product-related impurities are unintended variants of the drug substance that arise during production, purification or storage.

Common Examples of Product-Related Impurities

  • Protein aggregates (high molecular weight species)
  • Fragments (low molecular weight cleavage products)
  • Charge variants (e.g. deamidation, C-terminal lysine variants)
  • Oxidized or chemically modified forms
  • Glycosylation variants
  • Higher-order structure changes

How to Recognize Product-Related Impurities

Product-related impurities typically:

  • Share structural similarity with the target molecule
  • Arise from intrinsic instability in either the chemical environment in which the product finds itself or product processing conditions
  • Show consistent behavior across batches or stress conditions

However, confirmation often requires:

Lab research, scientist team and science innovation for medical healthcare, microscope dna and innovation with collaboration at work. Pharmacist engineer working on future medicine development

What Are Process-Related Impurities? (Definition + Examples)

Process-related impurities are contaminants introduced during manufacturing that are not part of the intended drug substance or active pharmaceutical ingredient (API).

Common Examples of Process-Related Impurities

  • Host cell proteins (HCPs)
  • Residual host cell DNA
  • Cell culture media components
  • Residual enzymes or reagents
  • Process additives
  • Leachables and extractables from materials
  • Residual solvents (where applicable)

How to Recognize Process-Related Impurities

Process-related impurities often:

  • Do not share structural similarity with the drug product
  • May be present at low levels or near detection limits
0104

Limitations of Single Analytical Techniques

Different analytical techniques, and the detection methods they rely on, measure different properties, such as size, mass, structure and interaction.

Methods that rely on a single structural characteristic may not provide sufficient information on the nature of the impurity, particularly for product-related impurities.

Relying on one method increases the risk of incomplete interpretation.

How to Identify and Interpret Impurities More Reliably

1. Use Orthogonal, Multi-Technique Analysis

A robust impurity analysis strategy combines complementary methods to build a complete picture. This is not always necessary for process-related impurities, but essential in most product-related impurity assessments. For process related impurities, BioPharmaspec provide a variety of methods for a significant range of impurities, including those from less common types of manufacturing processes which allow identification and quantitation down to low ppm/ppb levels.

2. Focus on Interpretation, Not Just Detection

Reliable conclusions depend on:

  • Understanding method limitations
  • Interpreting results across datasets
  • Evaluating behavior under different conditions

While quality control (QC) methods are designed to detect and monitor impurities, resolving complex or unclear results often requires more targeted, orthogonal analytical strategies.

Results must be evaluated in the context of molecular behavior, including how the product interacts, degrades, or responds to environmental conditions. This combination of focused experimentation and context-driven interpretation is what ultimately turns data into a clear, decision-ready understanding.

Why Accurate Impurity Evaluation Matters

  • Drug Development Decisions: Accurate evaluation ensures the correct root cause is identified. Failure to do this can lead to unnecessary process changes, increasing the risk of incorrect decisions and impacting process development strategies.
  • Regulatory Guidelines: Regulatory agencies require clear impurity identification and justification of batch differences to ensure drug safety and efficacy. Ambiguity often results in additional questions and delays in approval.
  • Risk and Timelines: Unresolved impurity issues tend to resurface later, often under tighter timelines. Early clarity reduces rework, development risk, and potential delays.

Key Takeaways

  • Product and process-related impurities are clearly defined
  • Analytical techniques provide clear insights
  • Accurate interpretation may require multi-technique analysis and expert understanding of the methods and data generated

Speak to a Scientist About Your Impurity Challenges

BioPharmaSpec supports complex biologics projects through multi-technique analysis and expert-led interpretation, turning challenging data into clear, decision-ready insights.

If you’d like to discuss a specific challenge, speak directly with a scientist.

FAQs

Explore Further